MarketWatch Logo Go to the homepage.

Ticker Name Last Chg Chg %
ACB Aurora Cannabis Inc. 1.07 0.04 3.88%
CRON Cronos Group Inc. 9.05 0.29 3.31%
CGC Canopy Growth Corp. 17.53 1.94 12.44%
WEED Canopy Growth Corp. 24.57 2.69 12.29%
GWPH GW Pharmaceuticals PLC ADR 105.85 0.18 0.17%
TLRY Tilray Inc. Cl 2 8.40 0.33 4.09%

More from Cannabis Watch

Read full story

Pot shops are considered ‘essential’ businesses in most states where it’s legal, but the rules are shifting

When California became the first state to issue a shelter-in-place because of the COVID-19 pandemic, it set another standard by declaring cannabis an “essential business.” But just as states’ overall responses to the pande...

Read full story

Cronos stock rises after earnings, restating several quarters of financial statements

Shares of marijuana producer Cronos Group Inc. rose 2.4% in the extended session Monday after the company restated several quarters of results and reported revenue below the consensus estimates.

Read full story

Pot stocks plunge after another round of disappointing earnings

Marijuana producer Hexo Corp. led cannabis stocks down Monday, falling 21% after the company reported earnings that were hit by write-downs.

Read full story

COVID-19 a ‘net positive’ for marijuana producer Curaleaf, says analyst

The COVID-19 pandemic has proven a boon to U.S. marijuana producer Curaleaf Holdings Inc., as sales jump and many states say that cannabis is an essential service, an analyst wrote in a note to clients Wednesday.

Read full story

Exclusive: Pot company Cronos receives SEC inquiry

The Securities and Exchange Commission has sent an inquiry to Cronos Group Inc., one of the largest cannabis producers in Canada, requesting the company retain records related to how it recognizes certain revenue, accordin...

Read full story

Pot smokers stock up for pandemic on ‘the vice of choice when alone’

As Americans faced seclusion due to the COVID-19 pandemic, shoppers in San Francisco had the option of stocking up on one popular product with a minimal amount of human interaction: Marijuana.

Read full story

Tilray sells stock for less than $5 a share, and that may not bode well for Aurora and Hexo

Investors bludgeoned Tilray Inc. stock Friday, sending shares of the Canadian cannabis producer down more than 30% after the company offered investors shares at less than a third of the price paid in its initial public off...

Read full story

Canopy Growth shares fall 7% on news of job cuts as cannabis sector sells off

Canopy Growth Corp. shares fell 4% Thursday after the Canadian cannabis company announced it was cutting 500 jobs as it reduces capacity by closing two greenhouses and shelving plans for another.

Read full story

Coronavirus and cannabis: Vape supply is a concern due to China shutdown

Amid a widespread market selloff due to investor concerns about COVID-19, cannabis companies will have to contend with disruptions involving vaporizer hardware, the vast majority of which is produced in China.

Read full story

Federal prosecutors investigate California marijuana companies in wide-ranging probe

Federal prosecutors have launched a probe of cannabis companies in California, seeking a batch of records held by a startup that functions as a Yelp for marijuana dispensaries, according to a grand-jury subpoena reviewed b...

Read full story

Tilray slides 14% to pressure broader cannabis sector after earnings disappoint

Tilray Inc. stock was the biggest decliner among Canadian licensed cannabis producers on Tuesday, as analysts weighed in on weaker-than-expected fourth-quarter earnings that included a revenue miss and $112 million impairm...

Read full story

Tilray stock drops after revenue miss, $112 million impairment charge

Tilray Inc. shares dropped more than 12% premarket Tuesday after the weed company posted revenue that missed Wall Street estimates and a larger than expected loss.

Read full story

GW Pharma's marijuana-derived epilepsy drug sales continue to climb

GW Pharmaceuticals Inc. reported revenue that topped the consensus estimates Tuesday, as the company’s marijuana-derived epilepsy drug continue to grow.

Read full story

Aurora Cannabis downgraded as Canadian sector struggles—but one analyst is upbeat

Cowen downgraded Aurora Cannabis Inc. along with Tilray Inc. and Sundial Growers Inc. on Monday with analysts becoming increasingly cautious on the outlook for Canadian licensed producers.

Read full story

Canopy Growth extends gains, but analyst highlights issue that was overlooked in earnings

Canopy Growth Corp.’s U.S.-listed shares rose Monday, extending gains made Friday after the Canadian cannabis company surprised investors with better-than-expected earnings.

Read full story

From cash to ash: Pot companies have just months to live on average, study finds

The largest Canadian marijuana companies have less than a year’s worth of cash left on average, according to a new study.

Read full story

Canopy’s stock roars higher after better-than-expected earnings, sparks broad rally in cannabis sector

Canopy Growth stock roared higher Friday and sparked a broad rally among cannabis stocks, after a better-than-expected earnings report bolstered sentiment on the beaten-down sector.

Read full story

People want cheap weed, and Aurora Cannabis is paying the price

Canadians want cheap weed, which isn’t great for companies that want to make expensive cannabis.

Read full story

Aurora Cannabis shares rise after a dire earnings report and $1 billion loss

Aurora Cannabis Inc. shares rose Thursday, after the company posted a set of earnings that were mostly expected, after the company last week unveiled a major overhaul of its operations.

Read full story

Canopy Growth earnings: When will the weed drinks arrive?

Still the world’s largest weed company by market value, Canopy Growth Corp. and its bet on weed beverages have not blossomed exactly the way investors were promised.

欧美成AⅤ人片在线观看